This blog documents Caroline's cancer journey. November 2017: Diagnosed with Stage IV, High-Risk Neuroblastoma...April 2019: Completed treatment protocol and declared to have no evidence of disease; enrolled in DFMO Clinical Trial...April 2021: Completed DFMO clinical trial...April 2022: Neuroblastoma Relapsed...June 2023: Completed treatment protocol and declared to have no evidence of disease; enrolled in “compassionate use” high-dose DFMO clinical trial.
Tuesday, November 8, 2022
Cycle 9 Admission
After getting bumped for treatment 3 weeks in a row, Caroline finally "made counts" yesterday, and was able to be admitted for Cycle 9. One of her chemotherapies has been reduced by 25% to (hopefully) aid in an easier recovery post-treatment. However, she's had a really rough start already - intense nausea is the biggest challenge - but her team is doing their best to get her some relief. If this ends up being a “typical” cycle, we anticipate being inpatient through Saturday.
Please continue to pray for Caroline, specifically for overall comfort and alleviation of her nausea.
We’re so grateful for all the support! Team Lantz #carolinestrong #ftgf
Getting an EKG before adding more anti-nausea meds to the regimen...